Literature DB >> 15513732

Research directions in augmentative and alternative communication for preschool children.

R A Sevcik1, M A Romski, L B Adamson.   

Abstract

PURPOSE: To review issues related to the use of augmentative systems with young children and present a case study of one child and family's experience with the System for Augmenting Language (SAL).
METHOD: The case involved a preschool child with severe developmental delays who had little functional speech. Acquisition and use of graphic symbols on a speech-output communication device was studied in home and clinical settings. Language and communication behaviours of the child and his communication partners were observed and language assessment measures were collected.
RESULTS: Child engagement state varied across the two settings with a stable profile seen in the therapy setting and a clear increase at home. Child communicative attempts increased following the introduction of the augmented system. Parents reported successful use of the SAL.
CONCLUSION: SAL is a viable communication intervention approach for young children.

Entities:  

Mesh:

Year:  2004        PMID: 15513732     DOI: 10.1080/09638280412331280352

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  3 in total

1.  A Technology-Assisted Language Intervention for Children Who Are Deaf or Hard of Hearing: A Randomized Clinical Trial.

Authors:  Jareen Meinzen-Derr; Rose Sheldon; Mekibib Altaye; Laura Lane; Lindsay Mays; Susan Wiley
Journal:  Pediatrics       Date:  2021-01-15       Impact factor: 7.124

2.  Augmentative and alternative communication for preschool children: intervention goals and use of technology.

Authors:  Katherine C Hustad; Kirsten Keppner; Amanda Schanz; Alycia Berg
Journal:  Semin Speech Lang       Date:  2008-05       Impact factor: 1.761

3.  Speech and language development in 2-year-old children with cerebral palsy.

Authors:  Katherine C Hustad; Kristen Allison; Emily McFadd; Katherine Riehle
Journal:  Dev Neurorehabil       Date:  2013-04-29       Impact factor: 2.308

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.